ESR1 and endometrial carcinoma: In addition, somatic alterations and splice variants in ESR1 have been associated with a hormone-independent activity, enabling ligand-binding independent transcriptional activity that seems to be associated with hormone-independent growth of breast and endometrial carcinomas (22-, , 25).